Protocolo de elección de tratamiento antifibrótico en Albacete

Abstract

Resume: Diffuse Interstitial Lung Diseases are uncommon pathologies. Among them the Idiopathic Pulmonary Fibrosis has an unfortunate prognosis, and had no treatment until a few years ago. Given the high cost of this treatment and its side effects and interactions, it is essential to establish a correct choice of antifibrotic treatment, when this is necessary.

Keywords

• Idiopathic pulmonary fibrosis
• pirfenidona
• nintedanib